Meet IQ’s 2015-6 Chair
March 16, 2015
As IQ gears up for its first board meeting in 2015, we are proud to introduce IQ's new Chair for 2015-6, Dr. Steve King. Watch Dr. King's participant profile to hear more about him and how IQ has helped the pharmaceutical industry. Click here to view more IQ Participant Profile Videos. Next up is Dr. Pierre Boulas, IQ's 2015-6 Vice Chair!
IQ Participant Profile – Steve King (IQ Chair 2015-6)
Dr. Steven A. King is Divisional Vice President of Development Sciences in Global Pharmaceutical R&D at AbbVie. Steve received a Ph.D. in 1988 from Stanford University and performed postdoctoral research at Princeton University. He joined the Process Research Department at Merck in 1990 and moved to the Process R&D group at Abbott in 1995. In 2004, Steve became Divisional Vice President, Process R&D.
In 2007, Steve took on a larger role and is currently responsible for four GPRD functions: Process R&D, Preclinical Safety, DMPK-BA (Drug Metabolism, Pharmacokinetics, and Bioanalysis) and Global Data Management and Statistics. During this same period GPRD has more than doubled throughput in its R&D pipeline.
Steve lives in Gurnee, IL with his wife, Sarah, and has two children, Brian and Audrey.